Airway Therapeutics
Latest round
- Series A
Last raised
- Sep 2014
Total raised
- $4.6M
Investors
- 3
About Airway Therapeutics
Airway Therapeutics, Inc.Founded in 2011 and headquartered in Cincinnati, US, Airway Therapeutics, Inc. is dedicated to developing treatments for respiratory conditions.50 mn.Airway Therapeutics specializes in developing innovative biologics aimed at addressing respiratory and inflammatory diseases, focusing on their flagship product, zelpultide alfa (AT-100). Zelpultide alfa is a recombinant human protein engineered to mimic the endogenous protein hSP-D, designed to reduce inflammation and infection while modulating the immune response, thereby disrupting the cycle of injury and inflammation associated with conditions like bronchopulmonary dysplasia (BPD).S.5 million globally.The revenue structure of Airway Therapeutics revolves around the commercialization of its biopharmaceutical products, particularly zelpultide alfa, through partnerships and clinical research agreements with hospitals and healthcare institutions. The company may engage in B2B transactions where healthcare providers purchase their products for use in clinical settings. Transactions could include supply agreements for zelpultide alfa tailored specifically for neonatal care and clinical trials involving preterm infants at risk for BPD.Airway Therapeutics aims to expand its product line by introducing new therapies addressing critical unmet needs in pediatric respiratory health. They are actively exploring additional markets across Europe and Asia by 2023 to enhance their global footprint.
Who invested in Airway Therapeutics
3 investors across 1 round
See all investors in Airway Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 10, 2014
Amount
$4.6M
Investors
Questions about Airway Therapeutics
Who invested in Airway Therapeutics?
Airway Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Airway Therapeutics raised?
Airway Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Airway Therapeutics last raise money?
Airway Therapeutics's most recent round on record is a Series A, in Sep 2014.
What does Airway Therapeutics do?
Airway Therapeutics is a biotechnology company.
Where is Airway Therapeutics headquartered?
Airway Therapeutics is headquartered in Cincinnati, US.
Which VCs invest in companies like Airway Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Airway Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Airway Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.